Clinical Trials · NCT07751133
Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- University College, London
- Enrollment
- 1,500
- Start date
- Aug 2026
- Locations
- See registry
- Primary endpoint
- Overall survival (primary efficacy)